Skip to main content
Clinical Trials/RBR-9dkn9ry
RBR-9dkn9ry
Active, not recruiting
未知

Clinical, biochemical and molecular aspects in patients with Fibrodysplasia Ossificans Progressiva before and after treatment with ascorbic acid, propranolol, hesperidine and epigallocatechin

niversidade Federal de Mato Grosso do Sul0 sitesAugust 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Fibrodysplasia Ossificans Progressiva
Sponsor
niversidade Federal de Mato Grosso do Sul
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 7, 2023
End Date
May 30, 2025
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de Mato Grosso do Sul

Eligibility Criteria

Inclusion Criteria

  • Individuals with clinical signs of classic FOP (and possible variants); both sexes; any age; term of consent/signed assent

Exclusion Criteria

  • Link to other experimental research proposals

Outcomes

Primary Outcomes

Not specified

Similar Trials